The change trend of late complications in patients with nasopharyngeal carcinoma treated by intensity-modulated radiotherapy:the clinician-and patient-reported outcomes
Department of Radiation Oncology,National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital,Chinese Academy of Medical Sciences and Peking Union Medical College,Beijing 100021,China
Abstract： Objective To investigate the change trend of late complications of patients with nasopharyngeal carcinoma (NPC) treated with intensity-modulated radiotherapy (IMRT) after 5-year follow up according to the clinician-and patient-reported outcomes. Methods From 2014 to 2015,NPC patients surviving> 5 years after radical IMRT at our outpatients department and were followed up 3 years later. The late complications were evaluated by the clinician based upon the CTCAE 4.0 rating criteria and assessed by patients themselves into 5 grades including very good, good, fair, poor and very poor. Results A total of 116 NPC patients were included in the first survey with a median follow-up time of 6.5 years (range,5.0-11.3 years).During the second survey, 21 patients were lost to follow-up, 7 patients developed nasopharyngeal recurrence or metastases, 7 patients had second primary tumors and 81 patients were eligible for final analysis. In the first survey, the most common clinician-reported ≥grade 2 late complications were subcutaneous fibrosis (n=17,21.0%) and hearing impairment (n=13,16.0%). The most frequent patient-reported “poor” and “very poor” late complications included dental caries (n=27,33.3%), subcutaneous fibrosis (n=17,21.0%) and hearing impairment (n=12,14.8%).During the second survey, the most common complications were aggravated or new late complications occurred including hearing impairment (n=16,20.0%),dental caries (n=16,20.0%) and posterior cranial neuropathy (n=9,11.0%). Conclusions The incidence of late complications is high after radical IMRT for NPC. During the long-term survival, subcutaneous fibrosis and hearing impairment are the main late complications. The incidence of hearing impairment, dental caries and posterior cranial neuropathy is increased over time. The symptoms of hearing impairment and dental caries are aggravated in partial patients.
Zhang Ye,Huang Xiaodong,Gao Li et al. The change trend of late complications in patients with nasopharyngeal carcinoma treated by intensity-modulated radiotherapy:the clinician-and patient-reported outcomes[J]. Chinese Journal of Radiation Oncology, 2018, 27(8): 721-726.
[1] 赵充,肖巍魏,韩非,等.419例鼻咽癌患者调强疗效及影响[J].中华放射肿瘤学杂志,2010,19(3):191-196.DOI:10.3760/cma.j.issn.1004-4221.2010.03.005. [2] 冯梅,范子煊,黎杰,等.582例鼻咽癌调强放疗 5年远期疗效及预后分析[J].中华放射肿瘤学杂志[J],2011,20(5):369-375.DOI:10.3760/cma.j.issn.1004-4221.2011.05.003. [3] 易俊林,高黎,黄晓东,等.416例鼻咽癌调强放疗远期生存与影响因素分析[J].中华放射肿瘤学杂志,2012,21(3):196-204.DOI:10.3760/cma.j.issn.1004-4221.2012.03.002. [4] 区晓敏,史琪,周鑫,等.鼻咽癌IMRT远期疗效和不良反应分析[J].中华放射肿瘤学杂志,2016,25(4):304-309.DO:10.3760/cma.j.issn.1004-4221.2016.04.002. [5] Zheng YJ,Han F,Xiao WW,et al. Analysis of late toxicity in nasopharyngeal carcinoma patients treated with intensity modulated radiation therapy[J].Radiat Oncol,2015,10:17.DOI:10.1186/s13014-014-0326-z. [6] Zeng L,Tian YM,Sun XM,et al. Late toxicities after intensity-modulated radiotherapy for nasopharyngeal carcinoma:patient and treatment-related risk factors[J].Br J Cancer,2014,110(1):49-54.DOI:10.1038/bjc.2013.720. [7] Tsai WL,Huang TL,Liao KC,et al. Impact of late toxicities on quality of life for survivors of nasopharyngeal carcinoma[J].BMC Cancer,2014,14:856.DOI:10.1186/1471-2407-14-856. [8] Wu LR,Liu YT,Jiang N,et al. Ten-year survival outcomes for patients with nasopharyngeal carcinoma receiving intensity-modulated radiotherapy:an analysis of 614 patients from a single center[J].Oral Oncol,2017,69:26-32.DOI:10.1016/j.oraloncology.2017.03.015. [9] Huang TL,Chien CY,Tsai WL,et al. Long-term late toxicities and quality of life for survivors of nasopharyngeal carcinoma treated with intensity-modulated radiotherapy versus non-intensity-modulated radiotherapy[J].Head Neck,2016,38(Suppl 1):E1026-E1032.DOI:10.1002/hed.24150. [10] 孔琳,张有望,吴永如,等.鼻咽癌放疗后长期生存者晚期副反应研究[J].中华放射肿瘤学杂志,2006,15(3):153-156.DOI:10.3760/j.issn:1004-4221.2006.03.001. [11] Xiao WW,Huang SM,Han F,et al. Local control,survival,and late toxicities of locally advanced nasopharyngeal carcinoma treated by simultaneous modulated accelerated radiotherapy combined with cisplatin concurrent chemotherapy:long-term results of a phase 2 study[J].Cancer,2011,117(9):1874-1883.DOI:10.1002/cncr.25754. [12] Wang W,Feng M,Fan Z,et al. Clinical outcomes and prognostic factors of 695 nasopharyngeal carcinoma patients treated with intensity modulated radiotherapy[J].Biomed Res Int,2014,2014:814948.DOI:10.1155/2014/814948. [13] Wang SZ,Li J,Miyamoto CT,et al. A study of middle ear function in the treatment of nasopharyngeal carcinoma with IMRT technique[J].Radiother Oncol,2009,93(3):530-533.DOI:10.1016/j.radonc.2009.09.013. [14] Chan SH,Ng WT,Kam KL,et al. Sensorineural hearing loss after treatment of nasopharyngeal carcinoma:a longitudinal analysis[J].Int J Radiat Oncol Biol Phys,2009,73(5):1335-1342.DOI:10.1016/j.ijrobp.2008.07.034. [15] Yao JJ,Zhou GQ,Lin L,et al. Dose-volume factors associated with ear disorders following intensity modulated radiotherapy in nasopharyngeal carcinoma[J].Scient Rep,2015,5:13525.DOI:10.1038/srep13525. [16] Zhang LL,Mao YP,Zhou GQ,et al. The evolution of and risk factors for neck muscle atrophy and weakness in nasopharyngeal carcinoma treated with intensity-modulated radiotherapy[J].Medicine,2015,94(31):e1294.DOI:10.1097/MD.0000000000001294. [17] Zhang LL,Wang XJ,Zhou GQ,et al. Dose-volume relationships for moderate or severe neck muscle atrophy after intensity-modulated radiotherapy in patients with nasopharyngeal carcinoma[J].Scient Rep,2015,5:18415.DOI:10.1038/srep18415. [18] 马春艳,刘雪融.患者参与式质量控制小组提高鼻咽癌放疗患者功能锻炼依从性的效果分析[J].中华现代护理杂志,2015,11:1258-1260.DOI:10.3760/cma.j.issn.1674-2907.2015.11.005. [19] Pow EH,McMillan AS,Leung WK,et al. Oral health condition in southern Chinese after radiotherapy for nasopharyngeal carcinoma:extent and nature of the problem[J].Oral Dis,2003,9(4):196-202. [20] Kam MK,Leung SF,Zee B,et al. Prospective randomized study of intensity-modulated radiotherapy on salivary gland function in early-stage nasopharyngeal carcinoma patients[J].J Clin Oncol,2007,25(31):4873-4879.DOI:10.1200/JCO.2007.11.5501. [21] Jawad H,Hodson NA,Nixon PJ.A review of dental treatment of head and neck cancer patients,before,during and after radiotherapy:part 1[J].Br Dent J,2015,218(2):65-68.DOI:10.1038/sj.bdj.2015.28. [22] Su SF,Huang Y,Xiao WW,et al. Clinical and dosimetric characteristics of temporal lobe injury following intensity modulated radiotherapy of nasopharyngeal carcinoma[J].Radiother Oncol,2012,104(3):312-316.DOI:10.1016/j.radonc.2012.06.012. [23] Zhou X,Ou XM,Xu TT,et al. Effect of dosimetric factors on occurrence and volume of temporal lobe necrosis following intensity modulated radiation therapy for nasopharyngeal carcinoma:a case-control study[J].Int J Radiat Oncol Biol Phys,2014,90(2):261-269.DOI:10.1016/j.ijrobp.2014.05.036. [24] Bakst RL,Lee N,Pfister DG,et al. Hypofractionated dose-painting intensity modulated radiation therapy with chemotherapy for nasopharyngeal carcinoma:a prospective trial[J].Int J Radiat Oncol Biol Phys,2011,80(1):148-153.DOI:10.1016/j.ijrobp.2010.01.026. [25] Luk YS,Shum JS,Sze HC,et al. Predictive factors and radiological features of radiation-induced cranial nerve palsy in patients with nasopharyngeal carcinoma following radical radiotherapy[J].Oral Oncol,2013,49:49-54.DOI:10.1016/j.oraloncology.2012.07.011. [26] Kong L,Lu JJ,Liss AL.Radiation-induced cranial nerve palsy:a cross-sectional study of nasopharyngeal cancer patients after definitive radiotherapy[J].Int J Radiat Oncol Biol Phys,2010,79(5):1421-1427.DOI:10.1016/j.ijrobp.2010.01.002. [27] Lin YS,Jen YM,Lin JC.Radiation-related cranial nerve palsy in patients with nasopharyngeal carcinoma[J].Cancer,2002,95(2):404-409.DOI:10.1002/cncr.10668.
2018, Vol. 27 
